TSX News -
goeasy Ltd. Provides Shareholder Update
MISSISSAUGA, Ontario, Dec. 10, 2018 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY) (“goeasy” or the “Company”), a leading full-service provider […]
Pascal Biosciences Announces Year-End Investor Update Webcast
Advancement of Cannabinoid Cancer Programs and Corporate Review to be Presented Scheduled for Dec. 17, 2018 at 1:30 p.m. Pacific […]
CORRECTION – BRT APARTMENTS Reports Fourth Quarter and Fiscal Year 2018 Results
GREAT NECK, N.Y., Dec. 10, 2018 (GLOBE NEWSWIRE) — BRT APARTMENTS CORP. (NYSE:BRT), a real estate investment trust that owns, […]
TSX News -
Athabasca Oil Corporation Announces $265 Million Leismer Infrastructure Transaction, Preliminary 2019 Capital Guidance of $95 – $110 Million and Streamlined Cost Structure
CALGARY, Alberta, Dec. 10, 2018 (GLOBE NEWSWIRE) — Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to […]
Solar Alliance extends Warrant Expiry Date
VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR) […]
Golden Leaf Holdings announces change in Board of Director composition
PORTLAND, Ore., Dec. 10, 2018 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a […]
Cryptobloc Provides Date for Reinstatement and Corporate Updates
VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) — Cryptobloc Technologies Corp. (“Cryptobloc” or the “Company”) (CSE: CRYP, OTC: CRYBF, […]
TSX News -
North American Palladium Announces Non-Brokered Flow-Through Private Placement Financing of Up to $5,000,000
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS […]
Wright Medical Group N.V. Announces Payment Date and Record Date for CVR Product Sales Milestone Payment
AMSTERDAM, The Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ:WMGI) today announced a contingent value right […]
Y-mAbs Therapeutics Announces FDA Clearance of IND for its Bispecific GD2 Antibody
NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical […]
